Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: A meta-analysis
OncoTargets and Therapy | Feb 13, 2018
Tang LN, et al. - Whether or not ABCG2 gene polymorphisms are associated with the risk of gefitinib-induced toxicity in non-small cell lung cancer (NSCLC) patients was investigated. In NSCLC patients, while the ABCG2 C421A polymorphism might not be a reliable marker of gefitinib-related toxicity, gefitinib-induced skin toxicity may be predicted by the ABCG2 G34A genotype.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
